15 Fastest Growing Biotech Companies in the US
In this article we talk about 15 fastest growing biotech companies in the US. You can skip our detailed analysis of the biotech industry and go to 5 Fastest...
Posts Tagged ‘NASDAQ:EDIT’
Is EDIT A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms...
Hedge Funds Have Never Been This Bullish On Editas Medicine, Inc. (EDIT)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Do Hedge Funds Love Editas Medicine, Inc. (EDIT)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Did Hedge Funds Drop The Ball On Editas Medicine, Inc. (EDIT) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on...
Is Editas Medicine, Inc. (EDIT) Going to Burn These Hedge Funds?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and...
Is Editas Medicine, Inc. (EDIT) A Good Stock To Buy?
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter,...
Here is What Hedge Funds Think About Editas Medicine, Inc. (EDIT)
Is Editas Medicine, Inc. (NASDAQ:EDIT) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of...
Is Editas Medicine, Inc. (EDIT) A Good Stock To Buy?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity...
Is Editas Medicine, Inc. (EDIT) A Good Stock To Buy?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don&#...
Top Performing Investor Adds Editas Medicine (EDIT), Sienna Biopharmaceuticals (SNNA) to Its Portfolio
You might have heard about Wildcat Capital Management and Leonard Potter before, although they are not as widely covered by financial websites like Warren...
3 Small-Cap Biotech Stocks That Could be Poised to Explode
With the threat of severe drug pricing regulations behind it for now, the biotech sector has launched a rally in recent days, with the iShares NASDAQ...
13D Filing: Polaris Venture Partners VI, L.P. and Editas Medicine Inc (EDIT)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
10 Most Interesting Companies In The World
If you were to draw up a list of the most interesting companies in the world, what would it look like? What exactly makes a company interesting to other...
Here is What Hedge Funds Think About Editas Medicine Inc (EDIT)
You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it...
13G Filing: Deerfield Management Reveals 5% Stake in Newly-Public Editas Medicine, Inc. (EDIT)
Form 13G’s must be filed with the SEC upon any investor or entity amassing at least 5% of a company’s outstanding shares, or alternatively...
13G Filing: Viking Global and Editas Medicine, Inc. (EDIT)
As a new 13G filing with the US Securities and Exchange Commission showed, Andreas Halvorsen‘s Viking Global holds a long position in Editas Medicine...
Billionaire Andreas Halvorsen Buys Shares of New Public Company, Bill Gates’ Cascade Bullish on AutoNation Inc. (AN), and More
Although the hedge fund industry as a whole lost money in 2015, the top 20 hedge fund managers generated roughly $15 billion net of fees last year. Therefore...
